Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × toripalimab × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Neoplasm Metastasis 2 Head and Neck Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Nasopharyngeal Neoplasms 1 NSCLC 1 Muscle Invasive Bladder Cancer (MIBC) 1 Mouth Neoplasms 1 Melanoma 1 Local Advanced Non-small Cell Lung Cancer 1 Laryngeal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Malignant Solid Tumors 1 Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 15 Specimen Handling 13 Magnetic Resonance Spectroscopy 12 pembrolizumab 11 Cisplatin 10 durvalumab 7 Nivolumab 6 Cystoscopy 6 Docetaxel 5 avelumab 4 atezolizumab 4 Transurethral Resection of Bladder 4 Radiotherapy 4 Radiation 4 Paclitaxel 4 Mitomycin 4 Carboplatin 4 Biopsy 4 erdafitinib 3 enfortumab vedotin 3 cabozantinib 3 Standard of Care 3 Ipilimumab 3 Immunoglobulin G 3 Fluorouracil 3 Disulfides 3 CTLA-4 Antigen 3 sacituzumab govitecan 2 eribulin 2 dehydroftorafur 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡